Showing results (41-50 of 271) with videos related to
Sort By:
Pageof 28
Annals of Surgical Oncology|November 23, 2022
Simultaneous Hepatic and Visceral Resection: Preoperative Risk Stratification and Implications on Return to Intended Oncologic TherapyAndrew J Sinnamon, Eric Luo, Aileen Xu, et al.Cancers|May 14, 2022
Copy Number Alterations as Novel Biomarkers and Therapeutic Targets in Colorectal CancerElaine S Tan, Todd C Knepper, Xuefeng Wang, et al.BMC Infectious Diseases|October 12, 2017
Evaluation of a pulsed xenon ultraviolet disinfection system to decrease bacterial contamination in operating roomsLynn El Haddad, Shashank S Ghantoji, Mark Stibich, et al.Journal of Surgical Oncology|November 15, 2014
Selective efficacy of zoledronic acid on metastasis in a patient-derived orthotopic xenograph (PDOX) nude-mouse model of human pancreatic cancerYukihiko Hiroshima, Ali A Maawy, Matthew H G Katz, et al.AJR. American Journal of Roentgenology|August 24, 2012
Venous tumor thrombus in nonfunctional pancreatic neuroendocrine tumorsAparna Balachandran, Eric P Tamm, Priya R Bhosale, et al.Targeted Oncology|June 29, 2022
Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal CancerElaine S Tan, Wenyi Fan, Todd C Knepper, et al.Molecular Cancer Therapeutics|April 17, 2008
LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasisDavide Melisi, Satoshi Ishiyama, Guido M Sclabas, et al.Surgery|July 28, 2020
Combined use of advanced practice providers and care pathways reduces the duration of stay after surgery for gastrointestinal malignanciesKristy K Broman, Hansel Baez, Erin Mihelic, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 24, 2020
Risk of Bowel Obstruction in Patients with Mesenteric or Peritoneal Disease Receiving Peptide Receptor Radionuclide TherapyJonathan R Strosberg, Taymeyah Al-Toubah, Eleonora Pellè, et al.Journal of the American College of Surgeons|March 2, 2005
Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancerShane E Holloway, Adam W Beck, Luc Girard, et al.Pageof 28